Cadila Healthcare has informed that it has enclosed a copy of press release dated May 27, 2021 titled ‘Zydus seeks DCGI approval to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID infection’.
The above information is a part of company’s filings submitted to BSE.